A blog about chemistry, drug development, science, and technology
Schering Plough has said they will remain independent and are not looking for mergers at this time.
Schering’s Hassan Says Company Will Stay Independent
While this may be admirable, I don’t know if they can keep up with all the other larger companies. Bristol-Myers Squibb is another one that will in my opinion be gobbled up by someone else in the not to distant future. The pressure to continue growth and adding new chemical entities to the pipeline is strong and I think investors may overlook those who aren’t on the merging track.
i personally don’t think mergers are the answer to some of the current problems associated with discovering new drug candidates. I take the view that there are other things that can be done to improved the productivity. And moving the bottlenecks from one place to another is not the answer either. Many companies and services are focused on getting more candidates into development. However, having spent over 14 years on the development and manufacturing side of things, this many times only results in more projects of lower quality and spending money and then failing on the development side is much more expensive.
Technorati Tags: Schering-Plough
Bookmark it with:
|
del.icio.us
|
Digg it
|
Furl
|
Simpy
|
Spurl
|
My Yahoo!
|
[powered by WordPress.]
QDIS: blogging about chemistry, drug development, science and technology.

By Category
Chemistry, science, and technology for the future.

35 queries. 0.940 seconds
October 29th, 2007 at 2:42 pm
schering-plough is purchasing Organon API, a company who is riddled with backstabbing office personnel The Controler has caused nervous breakdowns of two of his employees because of his nastiness. Keeping the Controller at Organon API will mean lawsuits. He sits and cusses at the computer equipment…loud enough where everyone can hear. He comes into work drunk after hours. Schering…talk to Organon API employees and their last general manager before you walk into that mess.